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Gap junctions, specialised membrane structures that mediate cell-to-cell communication in almost all tissues, are composed of channel-
forming integral membrane proteins termed connexins. The activity of these intercellular channels is closely regulated, particularly by
intramolecular modifications as phosphorylations of proteins by protein kinases, which appear to regulate the gap junction at several levels,
including assembly of channels in the plasma membrane, connexin turnover as well as directly affecting the opening and closure (‘‘gating’’)
of channels. The regulation of membrane channels by protein phosphorylation/dephosphorylation processes commonly requires the
formation of a multiprotein complex, where pore-forming subunits bind to auxiliary proteins (e.g. scaffolding proteins, catalytic and
regulatory subunits), that play essential roles in channel localisation and activity, linking signalling enzymes, substrates and effectors into a
structure frequently anchored to the cytoskeleton. The present review summarises the up-to-date progress regarding the proteins capable of
interacting or at least of co-localising with connexins and their functional importance.
D 2004 Elsevier B.V. All rights reserved.Keywords: Gap junction; Channel gating; Channel assembly; Intracellular trafficking1. Introduction
Intercellular communication is of paramount importance
in allowing individual cells to successfully accomplish their
task in a coordinated manner in multicellular organisms and
tissues. Gap junctional intercellular communication (GJIC)
relies on the existence of intercellular protein channels that
span the lipid bilayers of adjacent cells and allow the direct
exchange of ions and small molecules between neighbour-
ing cells. Transmembrane proteins, termed connexins, have
a common topology, with four alpha-helical transmembrane
domains, two extracellular loops, a cytoplasmic loop, and
N- and C-termini located on the cytoplasmic membrane
face. The sequences are most conserved in the transmem-
brane and extracellular domains, yet many of the key
functional differences between connexins are determined
by amino acid differences in these domains. The junctional
channel is composed of two end-to-end hemichannels, each0005-2736/$ - see front matter D 2004 Elsevier B.V. All rights reserved.
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aqueous pore in the lipid bilayer.
GJIC was for a long time regarded as a relatively passive
way of intercellular signalling through cell-to-cell tunnels
before it finally appeared that the degree of intercellular
coupling is finely regulated in three main aspects: (i) the
number of channels present in the membrane, (ii) their
functional state and (iii) their unitary permeability.
The availability of membrane proteins, including junc-
tional proteins, at the cell surface can be regulated at different
locations within the cell: (1) the amount of protein synthes-
ised in the endoplasmic reticulum (ER) is largely controlled
by gene transcription. In addition, the ER quality control
system regulates the exiting of properly folded proteins from
the ER. (2) In the trans-Golgi network, proteins can either be
diverted directly to the lysosomes or be transported to the cell
surface. (3) At the plasma membrane, the endocytic machin-
ery can select proteins for endocytosis via clathrin-coated
pits or proteins may be subject to proteolysis, resulting in
shedding of the extracellular domain. (4) In endosomes,
internalised proteins are either recycled back to the plasma
membrane or targeted to the lysosome for degradation.
J.-C. Herve´ et al. / Biochimica et Biophysica Acta 1662 (2004) 22–41 23The open probability and elementary permeability of gap
junctional channels (as of a number of membrane channels)
are regulated by protein phosphorylation and dephosphory-
lation processes and several factors (including not only
intracellular pH and calcium concentrations, voltage but also
different chemicals). It is now becoming clear that such
regulations require the formation of multiprotein complexes
(for recent reviews regarding the involvement of connexins
in protein–protein interactions, see for example Refs. [1,2]).
While pore-forming-subunits of many channels bind to
auxiliary channel subunits, they also associate with scaffold-
ing proteins that play essential roles in channel localisation
and activity [3]. Scaffolding proteins link signalling
enzymes, substrates, and potential effectors (such as chan-
nels) into a multiprotein signalling complex that may be
anchored to the cytoskeleton. Besides an obvious role in
targeting the channel to a particular location on the cell
membrane, there are several advantages to having a mem-
brane channel in a multiprotein complex. Indeed, the sub-
strate selectivity of some enzymes, essential to determining
specificity in several signal transduction pathways, is largely
determined by their subcellular location (e.g. for protein
phosphatases). There is also a large increase in the efficiency
of the reaction kinetics when an enzyme is localised with its
substrate and effector in a microenvironment with restricted
diffusion. Moreover, the anchoring of enzyme complexes to
some channels may be necessary for the extremely rapid
transmission of signals required to regulate them. However,
if the proteins in signalling cascades are considered spatio-
temporarily organised in such a way to achieve efficiency
and specificity, the physical association of components to
form signalling complexes or their close proximity to facil-
itate random collisions remains poorly understood.
Many of the signalling pathways and regulatory systems
in eukaryotic cells are controlled by proteins with multiple
interaction domains that mediate specific protein–protein
and protein–phospholipid interactions. Pairs of interacting
partners at protein–protein (or protein–peptide) interfaces
interact via modular protein domains, well demarcated and
independently folded portions of proteins, typically com-
prising 40 to 200 amino acids. These domains are non-
catalytic and bind specifically to short continuous peptide
sequences in their binding partner(s) via one or more
exposed, ligand-binding surfaces (‘ligand recognition pock-
ets’). Ligands interact with their complementary domains
through short and generally continuous sequence motifs. In
some cases, certain amino acids of the ligands must be post-
translationally modified (e.g. phosphorylated or acetylated)
before recognition and binding can occur (for review, see
Ref. [4]).2. Methodological approaches
As protein–protein interactions are generally mediated
by the recognition of short continuous amino acid stretcheson target proteins by specific binding domains, several
strategies have successfully been used to define recognition
sequences for a large series of such protein domains. The
immunofluorescence confocal microscopy is used to inves-
tigate co-localisation of connexins with protein partners, to
examine if the similar subcellular localisation of two pro-
teins makes possible a physical interaction between them.
The two-dimensional distribution of integral membrane
proteins in cellular membranes can be studied by exposing
freeze-fracture replicas to antibody immunogold complexes.
Main biochemical approaches consist, in co-immunoprecip-
itation experiments and pull-down assays, using peptides
corresponding to known connexin sequences, fused to GST,
in which protein partners are identified by Western blot or
mass spectrometry. The two-hybrid system is the most
commonly used genetic method to identify the proteins with
which a particular protein associates via transcriptional
activation of one or several reporter genes. Such a method
is used to investigate whether two known proteins interact in
vivo and in native conformation, if the genes encoding both
proteins are available, or to identify previously unknown
proteins that interact with a protein of interest using a
specially constructed cDNA library. These same techniques,
coupled with truncation and mutagenesis experiments, are
used to define the region of interaction between pairs of
proteins. Surface plasmon resonance-based biosensor tech-
nologies allow the determination of the affinity and kinetics
of a wide variety of molecular interactions (including
protein–protein) in real time, without the need for a molec-
ular tag or label. Connexin–connexin interactions can be
investigated by translational diffusion analysis, using nucle-
ar magnetic resonance (NMR). In vitro cell-free assays are
performed either by means of liposomes reconstituted with
connexins extracted from plasma membrane post-transla-
tionally inserted connexins or by expression of different
connexin isotypes in translation-competent lysates and ER-
derived membrane vesicles (microsomes).3. Connexin–connexin interactions
The assembly of six connexin molecules into a con-
nexon, made of single (homomeric connexon) or multiple
(heteromeric connexon) connexin types appears to be based
on specific signals located within the connexin polypepti-
des. The end-to-end binding between two connexons occurs
via non-covalent interactions between the extracellular
loops of connexins, which each contains three conserved
cysteine residues that form intramolecular disulfide bridges.
Mutagenesis studies suggest that the docking region con-
tains beta structures, and may resemble to some degree the
beta-barrel structure of porin channels. The two hemichan-
nels that compose a junctional channel are rotationally
staggered by approximately 30j relative to each other so
that the alpha helices of each connexin monomer are axially
aligned with the alpha helices of two adjacent monomers in
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second extracellular (E2) domain [6] together with the
middle cytoplasmic portion [7] were found determinant of
heterotypic compatibility between connexins. The docking
process of connexons may be hindered by incubation of
cells with synthetic oligopeptides homologous to a specific
region of the second extracellular loop of connexins, plau-
sibly mimicking connexin–connexin binding, resulting in a
decrease of the activity of junctional channels in an aortic
smooth muscle cell line expressing Cx40 and Cx43 [8]. A
chimera in which the third transmembrane (and proposed
channel lining sequence of Cx32) was substituted by a
transmembrane sequence of the cystic fibrosis transmem-
brane conductance regulator (CFTR), did not oligomerise in
vitro and it accumulated intracellularly when expressed in
COS-7 cells [9].
Connexin–connexin interactions have been suggested to
be responsible for the interruption of the cell-to-cell com-
munication elicited by some agents (including pH, insulin or
pp60v-Src, for example), via interactions between the chan-
nel pore and a discrete C-terminal domain of the connexin
serving as gating particle, a ‘‘ball and chain’’, model [10–
17] similar to the inactivation of Shaker-type K+ channels
[18]. Several lines of evidence indeed imply that the
carboxyl terminal (CT) domain of connexins is a movable
structure, able to behave like an independent domain.
Indeed, the truncation of this domain (of Cx40 or Cx43
for example) resulted in alterations in their single channel
activity, but normal functions were restored by coexpression
of the CT domain, even of another connexin. It was for
example the case for Cx40 truncated at amino acid 248
(Cx40tr248), where separate coexpression of either the
homologous (Cx40) or the heterologous (Cx43) CT frag-
ments restored, at least partially, channel functions
[16,19,20]. These hetero-domain interactions (occurring
between the CT domain of one connexin isotype and the
pore-forming region of another) suggest that, despite their
differences in primary sequence, the CT domains of Cx40
and of Cx43 can reach a similar conformation, allowing
their interaction with a common binding domain. Such
intramolecular interaction, by analogy with other biological
reactions involving two separate molecules (e.g. hormone
and receptor), is seen as a intramolecular noncovalent
interaction of the CT domain (acting as a ligand) with an
amino acid domain in or near the mouth of conductive path,
(acting as a receptor). Further investigation is needed to
determine the regions of the CT and of the inner pore-
forming region involved in this gating.4. Connexins–partner proteins interactions
The peptide chains contain domains that mediate pro-
tein–protein interactions and, among them, postsynaptic
density-95/discs large/zona occludens-1 (PDZ) motifs are
one of the most commonly found. These domains are 80–100-amino acid protein binding cassettes, identified initially
in PSD-95, DLG, and ZO-1, that recognise a three-residue
peptide motif in the CT of their binding partners [21].
Among these domains, PDZ motifs bind to CT ends of
various proteins, especially integral membrane proteins,
most of which end in valine. PDZ proteins can be classified
into three principal families according to their modular
organisation (for review, see Ref. [22]). The Src homology
3 (SH3) domains (approximately 50–70-amino acid-long
domains) interact with proline-rich peptide motifs whereas
Src homology 2 (SH2) domains associate with short amino
acid sequences containing phosphotyrosine. Several
domains may be present in the sequence of a given protein.
Proteins of the membrane-associated guanylate kinase
(MAGUK) family for example are characterised by a
multidomain organisation that includes several PDZ
domains, one SH3 domain, and one GUK-like domain
(for review see Ref. [23]). This organisation allows
MAGUK proteins to serve as linkers between integral
membrane proteins and cytoskeletal networks. They can
indeed cross-link multiple integral membrane proteins at the
cytoplasmic surface of plasma membranes to establish
specialised membrane domains. The list of MAGUK pro-
teins, linkers between integral membrane proteins and
cytoskeletal networks, is growing rapidly. Several proteins
have been reported able to interact or to be co-localised with
different connexins (see Table 1).
4.1. Calmodulin
Calmodulin (CaM) now appears as a constitutive or
dissociable Ca2+-sensing subunit of a surprising variety of
ion channels found in a wide range of species from Homo
to Paramecium (for recent review, see Ref. [24]). The
ability of a non-specific CaM antagonist (trifluoperazine)
to prevent CO2-induced uncoupling of Xenopus embryonic
cells led to suggest that CaM may participate in channel
gating [25]. This hypothesis was strengthened by evidence
for CaM binding to Cx32 in gel overlays [26] and that a
fluorescent CaM derivative binds to Cx32 and Cx32 frag-
ments in vitro [27]. With inhibition of CaM expression, the
slow gating and CO2-sensitive gating virtually disappeared
whereas the expression of a CaM mutant (the N-terminal,
NT, hand pair replaced by a copy of the CT pair) dramat-
ically increased the chemical gating sensitivity of gap
junction channels composed of Cx32 and decreased their
sensitivity to transjunctional voltage [15], suggesting a
CaM participation in this mechanism. A direct CaM-con-
nexin interaction at junctional and cytoplasmic spots was
demonstrated by confocal immunofluorescence in HeLa
cells transfected with Cx32 and in cryosectioned mouse
liver [28]. Mirror resonance assays with peptides cor-
responding to some parts of the CT domain of Cx43 did
not detect interactions with CaM, but the authors suggested
it might occur via other regions of the Cx43 CT or
indirectly [17].
Table 1
Reported proteins able to interact or to co-localise with different connexins
Partner protein Cx Cx motif Main approachesa Cell typeb Refs.
Cx-Cx Cx43, Cx46, Cx50 bt Xenopus oocytes [6]
Cx32, Cx38, Cx43 bt Xenopus oocytes [7]
Cx32 M3, CT tail bt ci COS-7 cells [9]
Cx40, Cx43 Second extracellular
loop of Cx43
bt A7r5 cells [8]
Cx32, Cx43 bt Xenopus oocytes [10]
Cx32, Cx43 bt Xenopus oocytes [11]
Cx43 bt Xenopus oocytes [12]
Cx43 bt Xenopus oocytes [13]
Cx32, Cx43 bt Xenopus oocytes [14]
Cx32 CT tail bt Xenopus oocytes [15]
Cx32, Cx43 bt N2a cells [16]
Cx43 CT-L2 bt nmr at [17]
Cx37, Cx40, Cx43, Cx50 bt Xenopus oocytes [19]
Cx40, Cx43 bt N2a cells, Xenopus oocytes [20]
Calmodulin Cx32 NT (1-21) ;
CT (216-230)
bt [27]
Calmodulin Cx32 CT tail bt Xenopus oocytes [15]
M3, CT tail bt ci COS-7 cells [9]
cl Cx32-HeLa, cryosectioned mouse liver. [28]
ZO-1 Cx31.9 cl ci HEK 293 cells [48]
Cx32 cl ci Cultured rat hepatocytes [47]
Cx43 cl Epithelial cells of pig thyroid [32]
CT 5 amino-acids cl ci at Cx43-HEK 293 cells [35]
Extreme C-terminus cl ci dh Cx43-COS-7 cells [40]
Very CT isoleucine residue ci bt at COS-7, A431, Beas2B [76]
cl Porcine and equine uterine endometrium [37]
cl 42GPA9 Sertoli cell line [39]
cl ci at ROS 17/2.8 cells [31]
cl Rat adult ventricular myocytes [33]
cl ci em Rat adult ventricular myocytes [34]
cl Immortalised mouse hepatocytes [46]
cl ci Rat cardiomyocytes [36]
Cx45 CT 4 amino-acids cl ci dh MDCK cells [30]
12 most CT amino-acids cl ci at ROS 17/2.8 cells [31,45]
CX46, CX50 cl ci Mouse lens [49]
cl ci em at Mouse lens [50]
ZO-2 Cx32 cl Cultured rat hepatocytes [47]
Occludin Cx26 at Human intestinal cell line T84 [52]
cl ci CHST8 cells [38]
cl ci Cultured rat hepatocytes [47]
cl Immortalised mouse hepatocytes [46]
Cx43 cl Rat sciatic nerves [51]
Lin-7 Cx43 CT tail at bt cl [57]
Claudin-1 Cx32 cl ci Cultured rat hepatocytes [47]
cl Immortalised mouse hepatocytes [46]
h-catenin Cx43 cl ci Neonatal rat cardiomyocyte in culture [53]
cl Mouse neural crest cells [54]
a-catenin Cx26 and Cx32 cl em Mouse liver [55]
Cx43 cl ci Neonatal rat cardiomyocytes [36]
p120 Cx43 cl Mouse neural crest cells [54]
E-Cadherin Cx26 and Cx32 cl em Mouse liver [55]
N-Cadherin Cx43 cl Mouse neural crest cells [54]
pp60c-src Cx43 Y265 ci Rat-1 cells, COS-7, A431, HeLa cells [67]
CT tail at Neonatal rat cardiomyocytes, HEK 293 [44]
pp60v-src Cx43 CT-proline-rich region+
a phosphorylated
tyrosine residue
at ci Rat-1 fibroblasts, HEK 293 cells,
v-Src-transformed fibroblasts
[66]
CT tail cl ci v-Src-transformed fibroblasts [64]
PKCq Cx43 cl ci Neonatal rat cardiomyocyte in culture [68]
PKCa and PKCq Cx43 cl ci Human cardiomyocytes [69]
PKCa Cx43 cl Minipig hearts [70]
(continued on next page)
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Table 1 (continued )
Partner protein Cx Cx motif Main approachesa Cell typeb Refs.
DMPK Cx43 cl fs Rat papillary muscles [72]
cl Rat adult heart [73]
MAPK Cx43 at NRK, FT210 cells [74]
P38MAPK Cx43 cl Minipig hearts [70]
a-or h-tubulin Cx43 35 amino-acid domain
juxta-membrane region
CT tail
bt cl fs at Rat-1 cells, COS-7, A431, MDCK, HEK
293, T51B, Beas2B and human fibroblasts
[75,76]
Actin Gap junctions cl em Human and monkey lenses [79]
Cx43 cl SW-13 cells [77]
F-actin Cx43 cl Rat cultured astrocytes [80]
Drebrin Cx43 ci [81]
Caveolin-1 Cx43 cl ci fs NIH 3T3, HEK 293T and COS-7 cells [82]
Clathrin Cx43 cl Cultured cardiomyocytes of adult
Guinea pig
[84]
Ubiquitin Cx43 ci E36, BWEM cells [88]
em Cx43 HeLa cells [89]
em BICR/M1Rkcells [90]
CIP 62 Cx43 CT tail dh [91]
AP26 Cx26 cl P3/22, P3E1 cells [94]
NOV Cx43 cl C6 glioma cells 95
YAF2-like protein Cx26 cl dh [97]
(a) bt : biochemical techniques (cell-free assays, chimeras, truncated connexins, mimetic peptides, etc); cl: colocalisation; ci: co-immunoprecipitation; fs: co-
fractionation or co-sedimentation; dh: double hybrid; em: electron microscopy immunolabelling: at: affinity techniques (pull-down, affinity binding assays,
surface plasmon resonance); nmr: nuclear magnetic resonance.
(b) in roman characters, cells where Cx were endogenously expressed; in italics, cells where Cx were exogenously expressed, surexpressed or mutated.
A7r5, an aortic smooth muscle cell line
BICR/M1Rk, a permanently growing cell line derived from a spontaneous rat mammary tumour
BWEM, rat cardiomyocyte-derived cells
CHST8 cells, immortalised mouse hepatocytes
COS7, monkey African green kidney cells
E36 cells, Chinese hamster ovary cells
FT210 cells, a mutant cell line derived from FM3A, a murine mammary carcinoma cell line
HEK293 cells, human embryonic kidney 293 cells
MDCK, epithelial Madin–Darby Canine Kidney cells
NIH 3T3, mouse fibroblasts
NRK, rat kidney cells
N2a, murine neuroblastoma cells
P3/22, mouse skin papilloma cell line and its derivatives P3E1 (in which E-cadherin gene is transfected)
ROS 17/2.8, osteosarcoma cell line
SW-13, human adrenal cortical tumor cells
T51B cells, rat liver epithelial cells.
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4.2.1. Zonula occludens proteins
The ZO proteins are members of the MAGUK family
but, in addition to the presence of the characteristic modules
of this family (PDZ, SH3 and GUK domains), ZOs have a
distinctive CT comprising acidic- and proline-rich regions,
and splicing domains. The modular organisation of these
proteins allows them to function as scaffolds, which asso-
ciate to transmembrane junctional proteins, the cytoskeleton
and signal transduction molecules. ZO-1 for example is a
220 kDa peripheral membrane protein, which tethers trans-
membrane proteins such as occludin, claudin and junctional
adhesion molecule to the actin cytoskeleton. ZO-1 is both an
actin-binding and cross-linking protein and interacts with a
large number of proteins that are associated with the tightjunctions and the adherens junctions (for review, see for
example Ref. [29]).
The growing number of connexins that can associate
with ZO proteins indicates that the latter may play a more
general role in organising gap junctions and/or in recruiting
signalling molecules that regulate intercellular communica-
tion [30]. It was proposed that ZO-1 might make a scaffold
to temporarily secure the different connexins in gap junction
plaques at the cell–cell boundary, different domains of ZO-
1 serving as docking modules for kinases and phosphatases
that interact with the different connexin polypeptides [31].
4.2.1.1. Cx43. Cx43 and ZO-1 were found co-localised in
cell types as diverse as epithelial cells of the thyroid gland
[32], cardiac cells [33–36], endometrial epithelial cells [37],
an hepatocytic cell line [38], osteoblastic cells [31], a Sertoli
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Cx43 was surprisingly limited to low to moderate levels in
intact ventricular myocardium led Barker et al. [34] to
suggest that disruption of intercellular contacts between
myocytes might result in a dynamic change in the pattern
of association between ZO-1 and Cx43. The interaction of
Cx43 with ZO-1 occurred through the extreme carboxyl
terminus of Cx43 and the second PDZ domain of ZO-1 [40].
Moreover, in cardiac cells, ZO-1 would link Cx43 with a-
spectrin [35].
Gap junctions in cardiomyopathic heart cells were
reported to appear, in immunofluorescence microscopy, as
disparate rather than as dense particles as they do in normal
cardiac myocytes [41], suggesting an improper incorporation
of Cx43 into the gap junctional plaque in the cardiomyo-
pathic heart. Moreover, cardiomyopathic heart cells might
reduce gap junctional communication through c-Src-medi-
ated tyrosine phosphorylation of Cx43 [42]. The PDZ
domain of ZO-1 has been proposed to participate in such
protein–protein interactions [43], and in vitro binding assays
using recombinant proteins synthesised from regions of
Cx43 and ZO-1 showed that the CT tetrapeptide of Cx43,
DLEI, has the capacity to bind to the ZO-1 PDZ2 domain
[44]. According to these authors, the regulation of channel
functions by c-Src might be indirect, due to a conformational
hindrance, the c-Src-mediated tyrosine phosphorylation
allowing a binding with a SH2 domain, inducing a structural
change in the CT region of Cx43, thereby hindering the
interaction between Cx43 and ZO-1. In the adult rat ventri-
cle, ZO-1 and Cx43 co-distribute within intercalated discs,
but levels of association between Cx43 and ZO-1 increased
rapidly and significantly after partial or complete enzymatic
dissociation of myocytes from intact ventricle, a treatment
known to induce gap junction endocytosis.
4.2.1.2. Cx45. In transfected epithelial MDCK cells, Cx45
co-localises with endogenous ZO-1 at or near tight junctions
and co-precipitation experiments show that Cx45 and ZO-1
directly interact [30]. Cx45 binds to the PDZ domains of ZO-
1 and ZO-3, but not of ZO-2, via a short CT PDZ binding
motif. Inactivating this motif in Cx45 affects its co-precip-
itation and co-localisation with ZO-1 [30]. ZO-1, Cx43, and
Cx45 were found co-localised in osteoblastic cells, suggest-
ing that all three proteins are normally associated in the cells;
the interaction between the carboxyl terminus of Cx45 and
ZO-1 is likely to occur via binding to a ZO-1 PDZ domain in
the same manner as Cx43 CT [45]. The amino acid sequen-
ces of the CT of all connexins, with the exception of Cx32,
end in a hydrophobic residue suggesting that they might bind
to PDZ domains [21] in ZO-1. This might indicate that sets
of connexins that bind to ZO-1, like Cx45 and Cx43, could
be found in the same gap junctions along with ZO-1.
4.2.1.3. Other Cxs. ZO-1 proteins were co-localised with
Cx32, occludin and claudin-1 at cell borders of immortal-
ised mouse hepatocytes [46], whereas in primary culturedrat hepatocytes, Cx32 also co-localised with occludin,
claudin-1, ZO-1 and also ZO-2 (on the most subapical
plasma membrane) [47]. In lateral plasma membranes of
epithelial cells of pig thyroid, ZO-1 was co-localised with
Cx43 but not with Cx32 [32]. In human embryonic kidney
HEK293 cells transfected with the Cx31.9 gene, most ZO-1
staining co-localised to membrane domains with Cx31.9
[48]. As Cx43–ZO-1 interaction involves the most CT
residues of Cx43 and the second PDZ-domain of ZO-1,
Nielsen et al. [49,50] examined if two connexins of the lens,
Cx46 and Cx50, which possess CT residues similar to Cx43,
also interact with ZO-1. Both connexins were found to co-
immunoprecipitate and to co-localise with ZO-1.
4.2.2. Occludins and claudins
Occludin, a 65 kDa transmembrane phosphoprotein of the
tight junction with two extracellular loops, which frequently
co-localises with ZO-1 at regions of cell–cell contact, where
occludin can co-localise with Cxs, for example in rat sciatic
nerves with Cx43 [51] or in immortalised mouse hepatocytes
(Cx32-CHST8), where Cx32-binding was demonstrated by
immunoprecipitation [38]. These results indicate that con-
nexin can be aligned side-by-side with occludin into ordered,
linear fibrils when it is fused to the ZO-binding region, thus,
suggesting a scaffolding function for ZO-1, ZO-2, or ZO-3.
A potential link between a coiled-coil domain of occludin
and Cx26 was suggested in T84 cells [52].
Claudins form a multigene family (20 members) of c 22
kDa transmembrane proteins of the macromolecular tight
junction complex, and claudin-1 was found co-localised
with Cx32, occludin and ZO-1 at cell borders of rat
hepatocytes [47] and of a hepatocytic cell line [46].
4.3. Desmosomes and adherens junctions-associated
proteins
Adherens junctions and desmosomes, responsible for the
mechanical coupling of cardiac myocytes, are found closely
apposed to gap junction plaques at the intercalated discs,
which they link to the actin cytoskeleton.
Catenins are multifunctional proteins which include a-
catenin, h-catenin and plakoglobin (g-catenin), whose ac-
tivities depend on their subcellular localisation; plasma
membrane-associated h-catenin acts as a component of
cell-adhesive junctions, and it was found co-localised and
coimmunoprecipitated with Cx43 in neonatal rat cardio-
myocytes [36,53]. Catenin was suggested to interact, direct-
ly or indirectly via other components of cell junctions (such
as members of the cadherin family, PDZ-domain-containing
ZO-1 protein, or other cellular constituents), as part of a
complex within the junctional membrane. The intracellular
application of antisera against a-catenin, h-catenin (or ZO-
1) in cardiomyocytes cultured in low Ca2+ medium inhibited
the redistribution of Cx43 to the plasma membrane follow-
ing Ca2+ switch [36]. In mouse neural crest cells, p120
catenin-related was found co-localised with Cx43 and N-
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a-catenin were found co-localised with Cx26 and Cx32
during gap junction reappearance [55].
Lin-7 is a PDZ-domain-containing protein able to form
with Lin-2 and Lin-10 a heterotrimeric PDZ complex
involved in the organisation of epithelial and neuronal
junctions. Co-immunoprecipitation and in vitro binding
assays revealed that this protein directly binds to the C-
terminal sequence of h-catenin (for review, see for example
Ref. [56]). In a preliminary report, Singh et al. [57], using
tandem mass spectrometry analysis, identified mammalian
Lin-7 among proteins from whole cell lysates able to
interact with the C-terminal of Cx43. Deletion constructs
of Cx43 and the Lin family members confirmed, as well in
vitro as after expression in cells, these interactions, both
biochemically and via microscopic co-localisation.
Cadherins are an important family of cell adhesion
molecules, cell surface glycoproteins responsible for the
Ca2+-mediated adhesion of epithelial cells. Double staining
with anti-pan-cadherin and anti-Cx43 antibodies suggested
that Cx43 and cadherin were closely associated in mouse
heart sections [58]. N-cadherin is frequently co-localised or
closely juxtaposed with Cx43, for example in Novikoff cells
[59], adult rat cardiomyocytes in culture [60], or in mouse
neural crest cells [54]. In adult rat heart, only low to
moderate point-by-point co-localisation of Cx43 and ZO-1
was found within intercalated discs compared with the
relatively high level of co-localisation between N-cadherin
and ZO-1 [34]. In mouse hepatocytes, double-immunogold
electron microscopy using a polyclonal antibody for con-
nexins (Cx26 and Cx32) and a monoclonal antibody for E-
cadherin or alpha-catenin revealed co-localisation of these
molecules at cell-to-cell contact sites during the reappear-
ance of gap junction plaques [55]. A reduced level of E-
cadherin expression is frequently associated with invasive
tumours of epithelial origin, and E-cadherin transfection in
communication-deficient mouse skin papilloma cell line P3/
22 restored the function of connexins [61,62].
Cx43 and desmoplakin, a major component of the
desmosomal plaques (the structures which serve as attach-
ment sites for intermediate filaments) were observed in
close proximity in rat cardiomyocytes [60] and in mouse
heart [58].
4.4. Enzymes
Up to now, all enzymes found associated or co-localised
with connexins are protein kinases (PK). Among them, Src,
protein kinase C (PKC), mitogen-activated protein kinase
(MAPK) and casein kinase 1 (CK1) phosphorylate Cx43 at
different sites of its CT tail.
4.4.1. Scr protein tyrosine kinases
Expression of pp60v-Src completely blocked the commu-
nication induced by Cx43 but had only a modest effect on
communication through Cx32-made channels [63]. Cx43appeared as an endogenous substrate of pp60v-Src in v-Src-
transformed fibroblasts, and pp60v-Src and Cx43 were
shown to be partially co-localised in regions of the plasma
membrane; furthermore, pp60 v-Src could phosphorylate co-
immunoprecipitated Cx43 in an immune-complex kinase
assay [64]. Cx43 and pp60 v-Src co-immunoprecipitated
from v-Src-transformed fibroblasts, indicating that the two
proteins were associated and form a stable complex (see
Ref. [65]).
In vitro, Cx43 bound to the SH3 domain of v-Src, but not
of c-Src, and mutations in the SH3 and SH2 domains of v-
Src as well as in the proline-rich region or tyrosine 265 of
Cx43, reduced interactions between v-Src and Cx43 in vivo
[66]. In contrast, in cardiac myocytes, constitutively active
c-Src inhibits the endogenous interaction between Cx43 and
ZO-1 by binding to Cx43 [44]. Indeed, c-Src (Y527F)
prevents binding of Cx43 to the cytoskeletal protein ZO-1
by phosphorylating Tyr265, thereby providing a binding site
for the SH2 domain of c-Src, which directly disrupts the
interaction between the C-terminus of Cx43 and ZO-1. The
c-Src-mediated tyrosine phosphorylation of Cx43 not only
reduced gap junctional conductance but also decreased the
stability of Cx43 at the cell surface, leading to conclude that
the function of gap junctions is established by the interac-
tion of Cx43 with ZO-1 and is down-regulated when that
interaction is interfered by c-Src binding to a different site
[44,67].
4.4.2. Protein kinase C
The C-terminal tail of Cx43 has several serine residues
that could serve as PKC substrates. Co-localisation of the
various PKC isoforms with their putative substrates is
proposed to ensure their preferential and rapid phosphory-
lation on activation, and there is evidence suggesting that
PKC bind to specific anchoring proteins. Two PKC iso-
forms, PKCa and PKCq, localise to plasma membrane sites.
In non-stimulated myocytes of newborn rat, PKCq displayed
a discontinuous pattern of localisation at intercellular con-
tact sites and partial co-localisation with Cx43. Treatment
with FGF-2 or phorbol 12-myristate 13-acetate (PMA)
induced a more continuous pattern of PKCq distribution,
and the anti-Cx43 staining appeared to overlap extensively
with that of PKCq [68]; in failing or non-failing human
myocardium, both PKCa and PKCq co-localised with Cx43
[69]. In immunoprecipitation experiments, PKCq but not
PKCa co-precipitated with Cx43 in rat cardiomyocytes
[68], whereas PKCa was also present in the coimmunopre-
cipitated complex with either Cx43 or PKCq antibodies in
human cardiomyocytes [69]. In the last study, recombinant
PKCq or aincreased PKC activity significantly above en-
dogenous levels in the co-immunoprecipitated Cx43 com-
plexes, but phosphorylation of purified human Cx43 by
recombinant PKCa or q resulted in only PKCq-mediated
Cx43 phosphorylation. Thus, in the human heart, PKCa,
PKCq and Cx43 appear to form a closely associated
complex, and if only PKCq directly phosphorylates Cx43,
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within the Cx43 co-immunoprecipitated complex. In pre-
conditioned hearts of minipig, the co-localisation of PKCa
with Cx43 at intercalated discs increased during ischemia
[70].
4.4.3. Other protein kinases
Cellular co-immunoprecipitation experiments and in
vitro CK1 phosphorylation reactions shown that CK1 inter-
acted with and phosphorylated Cx43, initially on serine(s)
325, 328, or 330, and specific inhibition of CK1 activity
resulted in a decrease in assembled Cx43 [71].
Among myotonic syndromes, the myotonic dystrophy
(DM) is a dominantly inherited disease involving skeletal
muscles, heart, endocrine organs, lens and the central
nervous system. The molecular basis of this autosomal
disorder has been identified as the expansion of a CTG
repeat in the 3’ untranslated region of a gene encoding a
protein kinase, Myotonic Dystrophy Protein kinase
(DMPK). The pathophysiology of the disease and the role
of DMPK are still obscure. The main localisation sites of
this enzyme are neuromuscular and myotendinous junctions,
terminal cisternae of the sarcoplasmic reticulum in the
skeletal muscle and at intercalated discs in the cardiac
muscle. In the last site, DMPK was found co-localised with
Cx43 [72,73].
In NRK and FT210 cell lysates, Cx43 was seen to
interact and to be phosphorylated by activated MAPK
(ERK1 and ERK2; Ref. [74]). In tissue sections of minipig
heart, isoforms a and h of p38MAPK co-localised with
Cx43 and, in preconditioned hearts, this co-localisation
increased during sustained ischemia [70].
4.5. Cytoskeletal proteins
A 35-amino acid juxtamembrane region in the CT tail of
connexin-43 was proposed to contain a presumptive tubulin
binding motif [75]; a-tubulin and h-tubulin appeared
equally bound [76]. In contrast, in SW-13 adrenal cortical
tumour cells, no physical association between tubulin and
gap junction protein could be established [77]. In NRK
cells, the disruption of microtubules with nocodazole
inhibited the recruitment of Cx43 into gap junctions where-
as it had limited effect on the transport and clustering of
Cx26 [78].
A co-localisation of actin filament bundles and gap
junctions was observed in cortical fiber cells of human
and monkey lenses [79], and of F-actin and Cx43 in rat
cultured astrocytes [80]. In SW-13 adrenal cortical tumour
cells, Cx43 was observed at areas of cell-to-cell contact but
also within the cytoplasm as annular profiles, where it was
closely associated with actin and myosin II [77]. Drebrin,
one of the actin-binding proteins which regulate the struc-
ture and dynamics of the actin cytoskeleton, was found to
co-immunoprecipitate with Cx43 in brain membrane frac-
tions [81].4.6. Proteins involved in intracellular protein trafficking
Caveolins are structural proteins acting as scaffolding
proteins to cluster lipids and signalling molecules within
caveolae and sometimes to regulate those proteins (includ-
ing different membrane channels) that are targeted to the
caveolae. They are present in specialised lipid raft
domains, cholesterol-sphingolipid-rich microdomains that
function as platforms for membrane trafficking and signal
transduction. Cx43 was seen to co-localise, to cofraction-
ate, and to coimmunoprecipitate with caveolin-1 [82]. In
the latter study, some other connexins (Cx32, Cx36, and
Cx46) also seem targeted to lipid rafts, while Cx26 and
Cx50 were specifically excluded from these membrane
microdomains.
In Cx43-C6 glioma cells, immunogold labelling with
anti-Cx43 serum revealed that some of membrane Cx43
proteins were in proximity to clathrin-coated pits [83]. In
cardiomyocytes of adult guinea pig cultured for 2 weeks at
low density to prevent formation of cellular contacts,
immunoreactive Cx43 decreased and became progressively
localised under a nearly uniform punctate pattern throughout
the sarcoplasm, costained with clathrin, without detectable
co-localisation with actin or tubulin [84].
Ubiquitination is a post-translational modification in
which ubiquitin chains or single ubiquitin molecules are
appended to NT amino acid residue of the target proteins,
giving rise to poly- or monoubiquitination, respectively.
However, in some cases, as for p53, the ubiquitination does
not occur in the N-terminus [85]. Polyubiquitination targets
selected proteins for destruction by the proteasome via two
discrete and successive steps: (1) conjugation of multiple
moieties of ubiquitin to the protein, and (2) degradation of
the conjugated protein by the 26S proteasome complex with
the release of free and reusable ubiquitin [86]. In a few
cases, it has been reported that monoubiquitination targets
membrane-anchored proteins to degradation or recycling in
the lysosome/vacuole [87]. In E36 Chinese hamster ovary
cells, immunoprecipitation using anti-Cx43 antibody fol-
lowed by re-immunoprecipitation by anti-ubiquitin antibody
demonstrated polyubiquitination of Cx43 [88]. Immunogold
labelling of replicated material with an anti-ubiquitin anti-
body revealed that gap junctional plaques contained ubiq-
uinated proteins [89]; under control conditions, 50% of the
detected Cx43 junctional plaques were ubiquitinated [90]. In
these cases, the presence of ubiquitinated proteins might
reflect ubiquitination of either Cx43 or another protein
present in these structures.
4.7. Other partner proteins of connexins
Using a two-hybrid screen of an embryonic mouse
cDNA library, Jin et al. [91,92] identified 15 cDNAs coding
for protein domains that interact with the C-terminus of
Cx43. One of these cDNAs encoded the PDZ domain of
ZO-1, another a SH3 domain. A full-length 2.7 kb cDNA
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probe the cDNA coding for the SH3 domain. CIP62 was
predicted to encode a 760 amino acid protein with a
molecular weight of 82 kDa. Sequence analysis of the
derived peptide sequence revealed that the amino acid
region 497–545 was 64.5% similar to the SH3 domain of
human Grb2 proteins. The rest of the sequence was without
significant homology to proteins of known functions. Pre-
dominantly localised at the plasma membrane, this protein
might interact in vivo by its SH3 domain with the CT of
Cx43.
Organ of Corti Proteins 1 and 2 (OCP1 and OCP2), low-
molecular weight acidic proteins predominantly expressed
in the vertebrate auditory system (they each represent 5% of
the total proteins found in the OC) are components of OC-
specific ubiquitin ligases, which presumably bind selected
protein targets, positioning them for ubiquitination. Both
OCP1 and OCP2 were found co-localised with Cx26 in
postnatal guinea pig (see Ref. [93]).
In a preliminary report [94], a gene coding a protein
which specifically binds to the cytoplasmic loop domain of
Cx26, named Cx26-associated protein (AP26) and present
in many tissues of mouse and various cell lines, was cloned.
The co-localisation of AP26 and Cx26 and their coordinated
movement lead to suggest that AP26 might be a Cx26-
anchoring protein involved in Cx26 functions.
Nephroblastoma OVerexpressed (NOV) is a matricellular
protein, member with connective tissue growth factor
(CTGF) and Cyr61/Cef-10, of the CCN family, with nega-
tive growth-regulatory functions. High levels of NOV
(CCN3) expression are observed in smooth muscle cells
of the arterial vessel wall, in derivative of germ layersFig. 1. Possible domains of the C-terminal tail of Cx43 involved in interactions wit
been found involved in protein–protein interaction with partner proteins.during development, and its expression is altered in a
variety of tumours. Tumour cells often exhibit a low level
of Cx and a decreased GJIC. NOV co-localised with Cx43
at the cell membrane of C6 glioma cells transfected with
Cx43 [95]. There is an inverse relation between NOV
expression in glioma cells and their tumorigenicity, and
the establishment of functional GJIC was found associated
with NOV expression [96]. These authors also suggested
that the antiproliferative activity of NOV might involve a
reorganisation of cellular contacts, which play a crucial role
in tumorigenesis.
In a preliminary report, a yeast two-hybrid screen of
Cx26-interacting proteins allowed to isolate a mouse clone
homologous to the previously described human YY1-asso-
ciated factor (YAF2), a protein that interacts and modulates
the activity of the transcription factors YY1, Myc, and
MycN. In HeLa cells co-transfected with Cx26 and YAF2,
confocal microscopy revealed a co-localisation of those
proteins on the plasma membrane [97].5. Possible structural domains of connexins involved in
interactions with partner proteins
Cx43 is the most ubiquitous and the best known con-
nexin; its CT tail is not required for formation of functional
channels but is critical for the regulation of GJIC. Several of
its domains appear involved in interactions with partner
proteins (Fig. 1). Cx43 associates with ZO-1 via its extreme
CT, which interacts with the second, but not the first, PDZ
domain of ZO-1 [40], and the very CT isoleucine residue of
Cx43 was reported to be critical for ZO-1 binding [75].h partner proteins. Several domains of the C-terminal tail of the protein have
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tains a presumptive tubulin binding motif, necessary and
sufficient for tubulin binding. This motif (234KGVK
DRVKGK243, residues typically found in tubulin binding
domains are underlined) is unique for Cx43 and was not
found in the sequence of other connexin family members
[75].
Proline-rich regions of Cx43 associate with v-Src
by interacting with its SH3 domain (see Ref. [65]). Such
a region (50–70 amino acids long) possesses three
shallow pockets where the peptide ligands bind. Two of
the pockets are 25 A˚ long and 10 A˚ wide, large enough to
accommodate each of the prolines in the PxxP motif,
accompanied by a hydrophobic residue (i.e. A, I, L, V,
and P). Proline is indeed unique among the 20 common
amino acids in having the side-chain cyclised onto the
backbone nitrogen atom. This means that the conforma-
tion of proline itself is limited, with backbone angles of
f 65j. It also restricts the conformation of the residue
preceding the proline because of the bulk of the N-
substituent and results in a strong preference for a h-
sheet conformation. As a consequence, polyproline
sequences tend to adopt the PP II helix, which is an
extended structure with three residues per turn. This
implies that the two prolines in the SH3 domain ligand
core, PxxP, are on the same face of the helix and are thus
well placed to interact with the protein (see Ref. [98]).
Such sequence-specific ability of proline-rich regions to
interact with other proteins would explain how a peptide
of the same sequence as amino acids 271–287 of Cx43
(CSSPTAPLSPMSPPGYK) can prevent pH gating of
Cx43-expressing oocytes [99]. According to these authors,
the proline-rich region of the Cx43 CT is implicated in a
binding reaction that is critical for acidification-induced
channel closure. Proline-rich regions are also known
capable of binding to tubulin [98]. A mutational analysis
of Cx43 revealed that the hypothesised PDZ- and pre-
sumptive SH2/SH3-binding domains within the Cx43
carboxyl terminus are not required for this targeting event
or for its stable interaction with caveolin-1. In this study
[82], Cx43 appears to interact with two distinct caveolin-1
domains, i.e. the caveolin-scaffolding domain (residues
82–101) and the CT domain (135–178).
Phosphorylated tyrosine residues in the CT tail of Cx43
are able to bind to SH2 domains, of v-Src for example [66],
and it was suggested that such interaction might induce a
structural change in the CT region of Cx43, thereby hin-
dering the interaction between Cx43 and the ZO-1 PDZ-2
domain [44]. The region surrounding S364 in the CT was
suggested involved in interaction of Cx43 with intracellular
trafficking proteins [100].
Cx43, Cx46 and Cx50 have similar C-terminal tails;
transiently expressed Cx46 and Cx50 lacking the C-terminal
residues formed structures resembling gap junctions but did
not bind to the second PDZ domain of ZO-1, suggesting
that, as Cx43, their interaction with ZO-1 occurs via their C-terminal residues [50]. Cx31.9 was suggested to interact
with ZO-1 through a molecular mechanism similar to that
described for Cx43 [48]. Cx45 was also found to interact
with the PDZ domains of ZO-1 and ZO-3 via its C-terminus
[30], and in vitro translated ZO-1 bound to an oligopeptide
corresponding to the final 12 amino acids in Cx45 [45].
Truncation experiments of Cx32 suggested that a crucial
gap-junction targeting sequence resides between amino acid
residues 207 and 219 on the cytoplasmic CT tail [101]. In
hepatocytes from Cx32-deficient mice transfected with
Cx32, Cx26, or Cx43 cDNAs, endogenous occludin was
in part localised at cell borders, co-localised with Cx32,
whereas neither was detected in parental cells or in Cx26 or
Cx43-transfected cells. However, this co-localisation was
not observed when hepatocytes were transfected with Cx32
truncated at position 220 [46]. Several amino acid sequences
in Cx32 were proposed as CaM-binding motifs, including
residues 1–21 (NT) and 216–230 (CT) [27] and parts of the
third transmembrane domain and of the CT-tail [9].6. Physiological importance of protein–protein
interactions
6.1. Intracellular trafficking of connexins
Steps in the synthesis, assembly, targeting to the mem-
brane and turnover of gap junction channels appear to
follow the general secretory pathway for membrane pro-
teins. All through life cycle, connexins are associated with
different protein partners, including other connexins mole-
cules, in homo or hetero-oligomers, as summarised in Fig. 2.
6.1.1. Hemichannel assembly
The formation of hexameric connexon hemichannels
involves dimeric and tetrameric connexin intermediates.
Removing the CaM-binding site located at the carboxyl tail
of Cx32 or cell exposure to either a CaM-binding synthetic
peptide or W7 (a naphthalene sulfonamide CaM antagonist)
limited the formation of connexons and caused their intra-
cellular accumulation [9]. Kausalya et al. [30] suggested that
their binding to ZO proteins could determine which con-
nexin types co-assemble into a particular connexon.
6.1.2. Targeting connexons to the membrane
GJIC is impaired in most tumours; however, connexin
genes are rarely mutated in tumours, whereas aberrant
localisation of connexins is frequently observed. Abnormal-
ities in connexin partner proteins, responsible for the intra-
cellular traffic control of connexins might then cause
aberrant localisation of connexins. For channel assembly,
partner proteins might function as cytoplasmic scaffolds in
organising membrane proteins into specialised membrane
domains. It was for example possible to combine the
cytoplasmic tail of occludin to transmembrane portions of
Cx32 to create chimeras, and such chimeras were able to
Fig. 2. Main steps of the life cycle of a connexin involving interactions with partner proteins. ER, endoplasmic reticulum; CGN, cis-Golgi network; TGN, trans-
Golgi network; L, lysosomes; P, proteasomes; AJ, annular junction. Evidence has been reported for oligomerisation within the membranes of either the ER or
the Golgi apparatus.
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important role for cytoplasmic proteins in the targeting of
these chimeras to the appropriate membrane subdomain
[102]. ZO-1 was suggested to provide a docking that
temporarily secures the different connexins in gap junction
plaques at the cell–cell boundary [31,35,40]. The over-
expression of the NT domain of ZO-1, which lacked the
ability to localise at cell–cell interfaces, disrupted the
transport of connexin-43-FLAG to the target site [35].
However, the fact that a truncated Cx43 lacking the CT
phosphorylation sites and the ZO-1-binding site can none-
theless form channels [103,104] showed that the interaction
with ZO-1 is not essential for the formation of functional
channels of Cx43. Indeed, Cx43 lacking the ZO-1 binding
domain remained able to form channels (although the level
of the incorporation into the cell surface and junctional
conductance was reduced by about 30–40% compared to
wild-type Cx43 [44]). In KO fibroblasts transfected with rat
Cx43 cDNA truncated at amino acid 257 (M257Cx43),immunolabel of M257Cx43/KO cells shown that significant
levels of truncated Cx43 resided within the cell cytoplasm,
with very little localising to interfaces [100]. In rat cardio-
myocytes, the binding of catenins to ZO-1 was suggested to
form a catenin–ZO-1–Cx43 complex, required for Cx43
transport to the plasma membrane during the assembly of
gap junctions [36].
The disruption of microtubules with nocodazole was
found to have varied consequences. It indeed exists several
possibilities for newly assembled connexons to be recruited
in GJ plaques to GJs. Connexon-containing transport
vesicles may fuse with the plasma membrane within the
plaques or at the outer margin of plaques, or transport
vesicles may fuse with nonjunctional parts of the membrane,
and connexons may then drift to the GJ plaques where they
can dock into complete junctional channels. In transfected
HeLa cells, the disruption of microtubules with nocodazole
had little effect on the assembly of Cx43-GFP gap junctions,
but perturbed assembly of Cx26-GFP gap junctions [105],
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into gap junctions whereas it had limited effect on the
transport and clustering of Cx26 [78]. In Cx43-HeLa cells,
the plasma membrane pool initially enabled connexon
accrual to the clusters but further accrual was inhibited,
suggesting that insertion of connexons occurred predomi-
nantly into the nonjunctional areas of membrane, followed
by lateral movement to reach the margins of channel clusters
[106]. In Cx43-MDCK cells, nocodazole was also without
effect on initiation but inhibited the growth of GJ [107].
Other different interactions with partner proteins appear
involved in connexon targeting; for example the removal of
the CaM-binding site located at the carboxyl tail of Cx32
resulted in an intracellular accumulation of intermediate
connexin oligomers, which failed to target to gap junctions
[9]. CK1 phosphorylation of Cx43 was suggested to ‘‘tag’’
the Cx43 connexon for assembly, and, without this marker,
assembly of Cx43 gap junction structures was reduced [71].
E-cadherin junction formation at high calcium was sug-
gested to induce the formation of actin cables, which
directly or indirectly transport connexins from the cyto-
plasm to the cell–cell contact membranes via the Golgi
apparatus [62]. Forced expression of Cx43 and Cx32 into an
invasive human cell line PC-3 and in several other andro-
gen-independent PCA cell lines resulted in intracellular
connexin accumulation, but the transient expression of a-
catenin facilitated the trafficking of both connexins to the
cell surface and induced gap junction assembly [108]. The
disruption of actin microfilaments by cytochalasin B had no
significant effect on the initiation of GJ assembly in Novik-
off hepatoma cells [109], whereas it inhibited the recruit-
ment and assembly of connexins (Cx26-YFP and Cx43-
GFP) into gap junctions in NRK cells, suggesting that the
recruitment of these connexins to the cell surface or their
lateral clustering into gap junctions plaques is, at least in
part, dependent on the presence of intact actin microfila-
ments [78]. AP26, which was seen to move to the cytoplas-
mic membrane with Cx26 but not with Cx43, might be a
Cx26-anchoring protein [94].
6.1.3. Movements of connexons within the membrane;
growth of junctional plaques
Connexin-specific interactions, for example the stable
interaction of Cx43 with caveolin-1, might allow partition
into lipid raft domains [82]. In Novikoff hepatoma cells, the
disruption of microtubules had no significant effect on the
initiation of GJ assembly, but microtubules appeared re-
quired for GJ growth [109]. Cardiomyocytes of adult guinea
pig kept in isolation maintained their ability to reconnect
with each other for up to at least 2 weeks, with redistributed
Cx43 co-localised with clathrin in vesicular-shaped struc-
tures [84]. In HEK293T cells, recombinant coexpression of
Cx26 with caveolin-1 recruits Cx26 to lipid rafts, where it
co-localised with caveolin-1. This trafficking event appeared
to be unique to Cx26, since the other connexins investigated
in the study did not require caveolin-1 for targeting to lipidrafts [82]. As recently suggested [57], PDZ domain-con-
taining protein complexes could play a pivotal role in
localising their target membrane proteins to specialised
membrane domains.
6.1.4. Docking of hemichannels
Gap junctions form with desmosomes, adherens junc-
tions and tight junctions specialised complexes joining
individual epithelial and endothelial cells. In mouse hep-
atocytes, both E-cadherin and a-catenin were found co-
localised with Cx26 and Cx32 during gap junction
reappearance; the cell-to-cell contact sites made by cad-
herin–catenin complexes as well as tight junctional
strands may then act as foci for gap junction formation
[55,60]. An antibody specific for N-cadherin inhibited gap
junction formation in embryonic chick lens cells [110].
The assembly of the adherens junction proteins (particu-
larly N-cadherin, a-catenin and h-catenin) was observed
at cell contacts at an earlier time than Cx43 junctions
[60,111] and seems to be a prerequisite for subsequent GJ
formation [60]. However, in corneal epithelial cells, the
presence of E-cadherin was not a prerequisite for the
assembly of Cx43 gap junctions [112].
6.1.5. Degradation of connexins
The turnover of cellular proteins is a highly organised
process that involves spatially and temporally regulated
degradation by the ubiquitin/proteasome system. In this
pathway, the covalent ligation of ubiquitin to the substrate
is a signal for recognition by the 26S proteasome. Recent
studies indicate that targeting of substrates of the ubiquitin
pathway to the proteasome is usually accomplished by the
ligation of a polyubiquitin chain assembled through K48-
G76 isopeptide bonds, rather than by ligation of mono-
ubiquitin. Sorting of transmembrane proteins to endo-
somes and lysosomes is mediated by signals present
within the cytosolic domains of the proteins. Most signals
consist of short, linear sequences of amino acid residues.
These signals are recognised with characteristic fine spec-
ificity by the components of protein coats, including
clathrin, adaptor protein (AP) complexes, and Disabled-2
(Dab2, which as other cytoplasmic adaptor proteins, has
no catalytic domains but possesses protein binding
domains and may thus participate in signal transduction
pathways or regulate protein traffic inside cells). As mono-
ubiquitination seems involved in endosome sorting and
lysosome targeting, it could be of interest to examine if
connexins wear such post-translational modifications.
Ubiquitin-mediated proteasomal proteolysis was reported
to be the major mechanism of degradation of connexin43
in E36 Chinese hamster ovary cells and rat cardiomyo-
cyte-derived BWEM cells [88], whereas in other cell
types, both the proteasome and the lysosome ways seem
involved [113]. In SW-13 adrenal cortical tumour cells,
the disruption of actin microfilaments by cytochalasin B
exposure resulted in a decrease in the average number and
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compared to control populations suggested that cytoskel-
etal elements containing actin and myosin II were in-
volved in the turnover of annular gap junction [77]. In
contrast, it had very limited consequences on the structure
or permeability of the developing junctions in Novikoff
hepatoma cells [109].
In Cx43-Skep 1cells, a tyrosine-based sorting signal
(YKLV) in the C-terminus of Cx43 was proposed to control
Cx43 turnover by affecting internalisation and targeting of
the protein for degradation in the endocytic/lysosomal
compartment [114].
The fact that both the lindane-induced interruption junc-
tional communicative between Sertoli cells [39] and the
disruption of intercellular contacts between myocytes, a
treatment inducing gap junction endocytosis [34], were
accompanied by an increased in direct interaction between
Cx43 and ZO-1 led to suggest a role for ZO-1 in the
turnover of Cx43 during or after gap junctional endocytosis
[34]. A Cx43 mutant that no longer binds ZO-1 exhibited an
increased turnover rate [44]. A redistribution of Cx43 from
cell–cell interfaces to cytoplasmic structures was for exam-
ple observed after junctional uncoupling occurring during
18 beta-glycyrrhetinic acid (18 h-GA) exposure [115–117]
or acute myocardial ischemia [118].
6.2. Cellular selectivity of gap junction formation
GJIC specificity allows the establishment of communi-
cation compartments, groups of cells joined to each other by
gap junctions but more rarely to cells of adjacent compart-
ments. Heterocellular coupling is observed both in vivo and
in mixed cultures (see for example Ref. [119]), but its
molecular basis is not elucidated. It might be based on the
differential expression of connexins, but also of molecules
required for GJ formation, particularly of cell adhesion
molecules. Several of them were found involved, in hetero-
cellular populations of cell types expressing Cx43, in the
control of specificity of gap junction formation. In mixed
cultures of rat fibroblasts and epithelial cells, exogenous E-
cadherin expression resulted in a 10-fold increase in heter-
ologous communication, whereas exogenous P-cadherin
expression had no effect [120]. In contrast, mutual expres-
sion of E-cadherin was insufficient to stimulate GJ forma-
tion between bovine epithelial cells and fibroblasts [119]. In
mouse L and rat Morris hepatoma cells, exogenous cadherin
induced strong cell–cell adhesion in both cell types, but had
opposite effects of communication [121]. In human skin,
normal melanocytes established GJIC with keratinocytes,
whereas melanoma cells did not; instead, melanoma cells
communicated among themselves and with fibroblasts. This
switch in communication partners was seen to coincide with
a shift from E-cadherin to N-cadherin expression during
melanoma development, and forced expression of E-cad-
herin in melanoma cells restored gap junctional compatibil-
ity with keratinocytes [122].6.3. Modulation of junctional channel activity
Reversible and dynamic protein phosphorylations are
considered as a pivot mechanism of the regulation of
essentially all cellular functions, including GJIC, but the
precise mechanisms remain unclear. The anchoring of
involved enzymes at specific subcellular sites is critical
for their functioning. The fact that junctional channel
activity is well preserved during intracellular cell dialysis
(in conventional whole cell mode of the patch-clamp tech-
nique (see Ref. [123]) and even after membrane excision
(when the membrane of one of the cells is mechanically
ruptured, whereas the second cell is investigated [124])
show that enzymes important in the regulation of the
channel permeability are firmly anchored in the channel
vicinity. In the scaffolding model proposed by Laing et al.
[31], the different domains of ZO-1 serve as docking
modules for enzymes (e.g. protein kinases and phospha-
tases), localising them in the vicinity of junctional channels.
Moreover, the modulation of GJIC by protein phosphor-
ylation/dephosphorylation events is probably more complex
than a direct connexin phosphorylation and increasing
evidence indicates that protein partners are involved. This
view is supported by a lack of correlation between the
degree of junctional coupling and the extent of Cx43
[99,125–129] or Cx45 phosphorylation [130]. Although
Cx26 cannot be phosphorylated [131], exposure of Cx26-
SKHepl transfected cells to PMA reduced Lucifer yellow
dye transfer and junctional conductance; moreover, it also
markedly shifted the unitary conductance distribution [132].
In cultured astrocytes, hypoxia markedly reduced the degree
of GJIC and Cx43 phosphorylation, but junctional uncou-
pling occurred prior to Cx43 dephosphorylation [133].
Conversely, various treatments induced changes in the
connexin phosphorylation status without alteration of GJIC
degree [134,135]. Taken together, these results suggest that
disruption of GJIC is not solely mediated by modification in
the connexin phosphorylation status but requires the partic-
ipation of additional regulatory components.
In transfected cell pairs, even in plaques large enough to
mediate coupling, only a small fraction of channels would
be open at the same time [136]. These authors suggested
that proteins localised in areas of cell–cell contact, might
promote connexon aggregation or clustering and proposed
that the latter may be necessary for channel opening.
Channel gathering was also found essential for the activity
of some other channels, Kv1.4 potassium channels for
example, of which channel clustering appears to be oblig-
atory for suppressing internalisation and requests the pres-
ence of a MAGUK protein [137].
The interactions among connexin isotypes with distinct
regulatory mechanisms could influence channel gating
properties and lead to the construction of a spectrum of
channels. For example, the introduction of Cx45 into a rat
osteosarcoma cell line ROS-17/2.8, which endogenous
expresses Cx43, altered intercellular coupling, a most likely
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Hetero-domain interactions (occurring between the CT
domain of one connexin isotype and the pore-forming
region of another) occur, that could provide a structural
basis for the charge and size selectivity of the channels, with
probable functional consequences, allowing a great versa-
tility of the functional modulation of gap junction channels
(see Ref. [139]).
In murine skin papilloma cells, the degree of GJIC was
significantly increased when cells were transferred from
low-calcium to high-calcium medium, with concomitant
depletion of G-actin stocks and rapid increase of F-actin
bundles, probably due to actin polymerisation [62]. Both
micro-injection of anti-actin antibodies or cytochalasin D
treatment decreased GJIC between rat cultured astrocytes,
suggesting that the morphological integrity of microfila-
ments is fundamental for GJIC [140]. Cell-to-cell dye
coupling was virtually eliminated in N-cadherin-deficient
cells of mouse neural crest, suggesting that N-cadherin
might modulate the gating of Cx43 junctional channels
[54]. The implication of sites on the CT domain of several
connexins (e.g. Cx43) in their regulation by different
kinases raises the question of the degree to which phos-
phorylation and ‘‘chemically’’ (pH, insulin, . . .) -induced
gating mechanisms may share common elements. A pos-
sible interaction of p120 and h-catenin with the cytoplas-
mic tail of Cx43 might be involved in conformational
changes of the latter, perturbing directly or indirectly the
channel activity [54]. In the ‘‘chain and ball’’ or ‘‘particle-
receptor’’ model of gating process, a part of the CT
domain of the connexin is able, either directly by physi-
cally blocking the pore or indirectly by allosteric mecha-
nisms, to obstruct the intercellular pore in response to
different stimuli, including reduced cytoplasmic pH
[10,11], insulin and insulin-like growth factor [12],
pp60v-src [13], transjunctional voltage dependence
[14,16,19,20] or CaM (‘‘cork gating’’, Ref. [15]).
6.4. Expression, localisation and activity of other proteins
Besides their role of pore-forming subunits, some con-
nexins now appear to mediate nonjunctional effects. Some
of their mutations may for example impair cellular cyto-
skeletal organisation; Cx32 formation and/or Cx32-mediat-
ed GJIC was suggested involved in the formation of
functional tight junctions and actin organisation [46]. In
the latter study, stable Cx32 transfection resulted in an
increase in circumferential actin filaments without a change
of actin protein. In cultured astrocytes, GJIC inhibition
during the formation of a monolayer resulted in discordance
of actin stress fibers between neighbouring cells [141],
whereas actin organisation remained unchanged in Cx43
knockout mice [142]. Forced expression of connexins
(Cx43 or Cx32) was found accompanied by a profound
reorganisation of the actin and myosin cytoskeleton in C6
glioma cells [143].In hepatocytes from Cx32-deficient mice, the expression
of tight junction proteins (occludin, claudin-1 and ZO-1)
was significantly higher after Cx32 transfection, whereas
Cx26 or Cx43 transfection never induced occludin expres-
sion [46]. Conversely, in this study, treatment with a GJIC
blocker (18 h-GA) resulted in decreases of occludin and
claudin-1 at cell borders in Cx32 transfectants, suggesting
that Cx32 formation and/or Cx32-mediated GJIC may
participate in the formation of functional tight junctions
and actin organisation. In Cx43-deficient cells of mouse
neural crest, the subcellular distribution of p120 catenin was
altered [54]. Intact microtubules seem dispensable for the
regulation of Cx43 gap-junctional communication, and it
was suggested that Cx43 might anchor microtubule distal
ends to gap junctions and influence microtubule properties
[75]. Connexins (particularly Cx43) hemichannels appear to
operate in nonjunctional regions of the plasma membrane,
interacting directly with intracellular signalling cascades
(particularly via activation of the Src/ERKs signal transduc-
tion pathway [144]). Connexins may thus provide intercel-
lular signalling but also sites where intracellular signalling is
transduced.7. Conclusions and perspectives
Junctional channels, as numerous other membrane
channels, are associated with a variety of molecules to
achieve their physiological functions. In addition to cou-
pling to auxiliary subunits that modulate the biophysical
properties of the pore-forming subunit, the channels have
been shown to interact with scaffolding proteins and
cytoskeleton, and such interactions are essential for the
channel regulation and targeting. There is increasing
evidence that gap junctions are, as tight junctions, macro-
molecular assemblies consisting of integral membrane
proteins and other proteins that bind to them. The char-
acterisation of protein–protein interactions of connexins
and of their functional importance is a recently emerging
field. In the case of Cx43, the most abundantly expressed
gap junctional channel-forming protein, able of binding
with different proteins, gap junctions may also form a
macromolecular structure, tentatively represented in Fig. 3.
As emphasised by Duffy et al. [145], it is interesting to
note that connexin and claudin multigene families share
analogous structural and physical properties. They both
exist as four transmembrane domain (tetraspan) proteins
with intracellular amino and carboxyl termini, and both
bind PDZ domains (either the first, for Cx43 [40], or the
second, for claudin-1 [146]) of the MAGUK protein ZO-1
within the cell. Connexins form hexamers surrounding a
hydrophilic pore allowing ions and small molecules to
pass from cell to cell, whereas claudins would form
hexamers that may create paracellular pores for ion and
molecular diffusion in the spaces between cells (for
review, see Ref. [147]).
Fig. 3. Round about gap junctions. Artistic view of some of the cellular proteins found associated with Cx43-made channels or in their close surrounding.
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suggests that the association of scaffolding proteins with
channels is part of a general mechanism that not only directs
channel localisation within a cell but is also essential for
regulation of channel function (for review, see for example
Refs. [148,149]). Anchoring of membrane channels at
specific subcellular sites is critical for their function, but
the mechanisms underlying channel localisation and clus-
tering are largely unknown. In the case of gap junctional
channels, partner proteins appears to regulate the gap
junction functions at several levels, including assembly of
the junctions in the plasma membrane, connexin turnover as
well as channel gating.
It is however essential to keep in mind that the identi-
fication of connexin partners (or of partners of other
membrane proteins, as membrane receptors, transporters,
and ion channels, of these proteins which span the plasma
membrane multiple times and fold into a special structure
involving non-linear peptide loops) request rigorous bio-
chemical evidences via multiple approaches. Co-localisation
observations in immunofluorescence microscopy need ad-
ditional approaches (including for example in vitro bindingassays, coimmunoprecipitation) to substantiate the interac-
tions between connexins and the identified proteins. On the
other hand, the screening of protein–protein interaction
frequently result in identification of interactions which,
although reproducible and specific, are not easily assessed.
This is mainly due to the fact that proteins are misexpressed
in a compartment from which they are typically excluded
and therefore may be exposed to a repertoire of proteins that
are not accessible in their natural situations. In addition, the
fusion of a protein or a protein fragment to an effector protein
(e.g. in two-hybrid or protein recruitment approaches) may
result in misfolding of the protein and exposure of protein
surfaces that are typically not accessible for association with
other proteins.
In conclusion, the importance of protein–protein inter-
action in the regulation of connexin trafficking, assembly
and disassembly, as well as the dynamic modulation of the
opening state of junctional channels are progressively gain-
ing support. Communication through gap junctions is sen-
sitive to a variety of stimuli, including changes in the level
of intracellular Ca2+, pH, transjunctional applied voltage
and phosphorylation/dephosphorylation processes. In any
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teins that interact with connexins is only a first step in a long
endeavour. The major challenges of the future are to
quantify the stoichiometry of these protein interactions, to
picture their geometry by microscopic and structural bio-
logical approaches, to reveal the dynamic regulation of gap
junctional complexes and, perhaps most importantly, to
understand the functional significance of these protein
interactions in cell-to-cell communication.Note added in proof
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